American Healthcare REIT, Inc. (AHR) stock analysis
In our weekly check, American Healthcare REIT, Inc. is graded B (A to F). Of 24 checks on debt, profit, cash flow and trend: 18 pass, warnings: 2, red flags: 4.
About American Healthcare REIT, Inc.
American Healthcare REIT, Inc. is a Real Estate company (REIT - Healthcare Facilities) based in the United States, listed on NYSE as AHR.
What our checks show for AHR
Red flags
- The net margin is only 3.6%: little room if costs rise.
- The dividend takes 193% of profit: little cushion if profit falls.
- The share count grew by 151% in 2 years: each shareholder owns a smaller slice.
- Return on capital (ROCE) is only 2.6%.
Warning signs
- Operating profit covers interest only 2.3 times: a weak year could make the payments hard.
- Earnings per share fell 26.4% a year over the last 3 years.
Strengths
- The net margin rose by 7.4 points over 5 years, to 3.6%.
- The gross margin is 15.7% and has risen by 1.3 points: pricing power is holding.
- Operating cash flow is 4.38x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 37.4% a year over the next years.
- Analysts expect revenue to grow about 15.3% a year over the next years.
- Revenue grew 18.2% a year over the last 3 years.
Similar companies
DOC · OHI · CTRE · HR · SBRA · VTR
Questions
What grade does American Healthcare REIT, Inc. (AHR) have?
In our weekly check, American Healthcare REIT, Inc. is graded B (A to F). Of 24 checks on debt, profit, cash flow and trend: 18 pass, warnings: 2, red flags: 4. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of AHR stock?
This week's biggest flags for American Healthcare REIT, Inc.: Thin margins, Dividend stretched, Share dilution. In total 6 of 24 checks show a warning or a red flag.
What does American Healthcare REIT, Inc. do?
American Healthcare REIT, Inc. is a Real Estate company (REIT - Healthcare Facilities) based in the United States, listed on NYSE as AHR.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis